TM4SF1 and neoplasm: Many researchers have implemented targeted antibody therapy [7, 8], antibody-directed enzyme prodrug therapy [9], radioimmunotherapy [10], and targeted therapy with conjugated anti-tumor drugs [11] directly targeting TM4SF1.